Back to top
more

Ecolab (ECL)

(Delayed Data from NYSE)

$219.79 USD

219.79
1,106,781

-0.99 (-0.45%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $219.78 -0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (74 out of 251)

Industry: Chemical - Specialty

Better trading starts here.

Zacks News

Newmont's (NEM) Q1 Earnings and Revenues Beat Estimates

Newmont's (NEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.

CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates

CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.

Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions

Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.

West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak

West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.

Unveiling Ecolab (ECL) Q1 Outlook: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Ecolab (ECL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

Methanex's (MEOH) Q1 Earnings & Revenues Surpass Estimates

Adjusted EBITDA of Methanex (MEOH) is hurt by lower year-over-year average realized prices in Q1.

Cleveland-Cliffs (CLF) Earnings & Revenues Lag Estimates in Q1

Cleveland-Cliffs (CLF) lags Q1 earnings and revenue estimates due to lower volumes.

Penumbra's (PEN) New Launch to Enhance Blood Clot Removal

Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.

Ingevity (NGVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Ingevity (NGVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Air Products (APD) to Build Hydrogen Refueling Station Network

Air Products (APD) has currently installed a temporary hydrogen mobile fueler on-site to supply to customers.

Reasons Why You Should Retain HealthEquity (HQY) Stock for Now

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes

GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.

Sherwin-Williams' (SHW) Q1 Earnings & Sales Lag Estimates

Consolidated net sales of Sherwin-Williams (SHW) decline mainly due to a decrease in volumes in the Consumer Brands Group and the Performance Coatings Group in North America in Q1.

Ecolab (ECL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Ecolab (ECL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights Atmos Energy, Ecolab and The Sherwin-Williams

Atmos Energy, Ecolab and The Sherwin-Williams are part of the Zacks top Analyst Blog.

Tirthankar Chakraborty headshot

3 Dividend Aristocrats to Take the Edge off Market Volatility

With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.

Sanghamitra Saha headshot

Play Disaster Recovery Stocks on Earth Day

Global warming has been wreaking havoc on earth and causing natural disasters. Hence, these disaster recovery stocks could be prudent investing options on Earth Day.

Cabot (CBT) Chosen for $5M DOE Grant to Aid Hydrogen Economy

Cabot (CBT) and its partners will utilize this money to help the implementation of fuel cells, which generate electricity by emitting only water.

Reasons Why You Should Retain Masimo (MASI) Stock for Now

Masimo's (MASI) R&D activities raise optimism about the stock.

CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits

CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.

Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis

Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.

Why You Should Add Inspire Medical (INSP) to Your Portfolio

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.

Sweta Killa headshot

Will Materials ETFs Gain Further as Q1 Earnings Unfold?

Going into the Q1 earnings season, earnings releases from the sector giants will determine the movement of these funds.